mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |